View Future GrowthBalaji Amines 過去の業績過去 基準チェック /26Balaji Aminesの収益は年間平均-18.5%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間6.2% 8.2%割合で 減少しています。 Balaji Aminesの自己資本利益率は7.9%であり、純利益率は11.7%です。主要情報-18.47%収益成長率-18.47%EPS成長率Chemicals 業界の成長17.68%収益成長率-8.16%株主資本利益率7.86%ネット・マージン11.73%前回の決算情報31 Mar 2026最近の業績更新分析記事 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.お知らせ • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026分析記事 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...すべての更新を表示Recent updatesお知らせ • Jun 09Balaji Amines Limited, Annual General Meeting, Jul 10, 2026Balaji Amines Limited, Annual General Meeting, Jul 10, 2026, at 12:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,043, the stock trades at a trailing P/E ratio of 39.6x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 3.8% over the past three years.Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. Independent Director Suhasini Shah was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.New Risk • May 26New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 18% per year over the past 5 years. High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.5% average weekly change).分析記事 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹1,833, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change).Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,492, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 36% over the past three years.お知らせ • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change).お知らせ • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,265, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.分析記事 • Jan 09Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...Price Target Changed • Nov 15Price target decreased by 7.5% to ₹1,709Down from ₹1,847, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₹1,229. Stock is down 40% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.分析記事 • Nov 14Balaji Amines Limited (NSE:BALAMINES) Screens Well But There Might Be A CatchWith a median price-to-earnings (or "P/E") ratio of close to 27x in India, you could be forgiven for feeling...Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹10.67 (vs ₹12.65 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.67 (down from ₹12.65 in 2Q 2025). Revenue: ₹3.48b (flat on 2Q 2025). Net income: ₹345.6m (down 16% from 2Q 2025). Profit margin: 9.9% (down from 12% in 2Q 2025). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.お知らせ • Nov 03Balaji Amines Limited to Report Q2, 2026 Results on Nov 10, 2025Balaji Amines Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 10, 2025Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).お知らせ • Jul 24Balaji Amines Limited to Report Q1, 2026 Results on Aug 02, 2025Balaji Amines Limited announced that they will report Q1, 2026 results at 3:30 PM, Indian Standard Time on Aug 02, 2025Reported Earnings • Jul 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.0b (down 15% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.お知らせ • Jul 10Balaji Amines Limited, Annual General Meeting, Aug 08, 2025Balaji Amines Limited, Annual General Meeting, Aug 08, 2025, at 12:00 Indian Standard Time.Price Target Changed • Jul 01Price target increased by 20% to ₹1,972Up from ₹1,640, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of ₹1,825. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.分析記事 • Jul 01Earnings Tell The Story For Balaji Amines Limited (NSE:BALAMINES) As Its Stock Soars 27%Balaji Amines Limited ( NSE:BALAMINES ) shares have continued their recent momentum with a 27% gain in the last month...Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,673, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 31x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.Reported Earnings • May 29Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.3b (down 13% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.お知らせ • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.お知らせ • May 18Balaji Amines Limited to Report Q4, 2025 Results on May 26, 2025Balaji Amines Limited announced that they will report Q4, 2025 results on May 26, 2025分析記事 • May 17Balaji Amines (NSE:BALAMINES) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...Buy Or Sell Opportunity • May 16Now 21% overvaluedOver the last 90 days, the stock has fallen 2.1% to ₹1,404. The fair value is estimated to be ₹1,163, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,312, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.分析記事 • Mar 25A Look At The Fair Value Of Balaji Amines Limited (NSE:BALAMINES)Key Insights The projected fair value for Balaji Amines is ₹1,139 based on 2 Stage Free Cash Flow to Equity Current...Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,358, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.分析記事 • Mar 04Take Care Before Jumping Onto Balaji Amines Limited (NSE:BALAMINES) Even Though It's 25% CheaperUnfortunately for some shareholders, the Balaji Amines Limited ( NSE:BALAMINES ) share price has dived 25% in the last...Buy Or Sell Opportunity • Feb 19Now 23% overvaluedOver the last 90 days, the stock has fallen 30% to ₹1,395. The fair value is estimated to be ₹1,130, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.分析記事 • Feb 18This Analyst Just Downgraded Their Balaji Amines Limited (NSE:BALAMINES) EPS ForecastsMarket forces rained on the parade of Balaji Amines Limited ( NSE:BALAMINES ) shareholders today, when the covering...分析記事 • Feb 16Earnings Report: Balaji Amines Limited Missed Revenue Estimates By 15%It's been a sad week for Balaji Amines Limited ( NSE:BALAMINES ), who've watched their investment drop 17% to ₹1,433 in...Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹10.24 (vs ₹15.24 in 3Q 2024)Third quarter 2025 results: EPS: ₹10.24 (down from ₹15.24 in 3Q 2024). Revenue: ₹3.21b (down 16% from 3Q 2024). Net income: ₹331.9m (down 33% from 3Q 2024). Profit margin: 10% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.お知らせ • Feb 05Balaji Amines Limited to Report Q3, 2025 Results on Feb 12, 2025Balaji Amines Limited announced that they will report Q3, 2025 results on Feb 12, 2025Buy Or Sell Opportunity • Jan 30Now 21% overvaluedOver the last 90 days, the stock has fallen 22% to ₹1,683. The fair value is estimated to be ₹1,385, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Earnings per share has declined by 25%. Revenue is forecast to grow by 42% in 2 years. Earnings are forecast to grow by 96% in the next 2 years.分析記事 • Jan 17What Does Balaji Amines Limited's (NSE:BALAMINES) Share Price Indicate?Balaji Amines Limited ( NSE:BALAMINES ), might not be a large cap stock, but it saw significant share price movement...分析記事 • Dec 31Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Price Target Changed • Nov 20Price target decreased by 12% to ₹2,328Down from ₹2,648, the current price target is provided by 1 analyst. New target price is 17% above last closing price of ₹1,996. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₹54.20 for next year compared to ₹63.22 last year.Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹12.65 (vs ₹10.71 in 2Q 2024)Second quarter 2025 results: EPS: ₹12.65 (up from ₹10.71 in 2Q 2024). Revenue: ₹3.56b (down 6.4% from 2Q 2024). Net income: ₹409.8m (up 18% from 2Q 2024). Profit margin: 12% (up from 9.1% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.お知らせ • Nov 14Balaji Amines Limited Announces Company Secretary ChangesBalaji Amines Limited announced that at the board meeting held on November 14, 2024, approved the resignation of Mr. Lakhan S. Dargad as Company Secretary of the Company with effect from closing of business hours on December 30, 2024. Appointment of Mr. Abhijeet S. Kothadiya as a Company Secretary of the Company with effect from December 31, 2024. Mr. Abhijeet S. Kothadiya is an Associate Member of the Institute of Company Secretaries of India having Membership No. 68288 having good amount of experience in corporate and allied laws.お知らせ • Nov 06Balaji Amines Limited to Report Q2, 2025 Results on Nov 14, 2024Balaji Amines Limited announced that they will report Q2, 2025 results on Nov 14, 2024分析記事 • Oct 23Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...分析記事 • Aug 13The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%The analyst covering Balaji Amines Limited ( NSE:BALAMINES ) delivered a dose of negativity to shareholders today, by...分析記事 • Aug 11Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than ExpectedShareholders might have noticed that Balaji Amines Limited ( NSE:BALAMINES ) filed its quarterly result this time last...Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹13.36 (vs ₹16.28 in 1Q 2024)First quarter 2025 results: EPS: ₹13.36 (down from ₹16.28 in 1Q 2024). Revenue: ₹3.93b (down 15% from 1Q 2024). Net income: ₹432.9m (down 18% from 1Q 2024). Profit margin: 11% (in line with 1Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.分析記事 • Jul 30At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?Balaji Amines Limited ( NSE:BALAMINES ), is not the largest company out there, but it saw a double-digit share price...お知らせ • Jul 26Balaji Amines Limited to Report Q1, 2025 Results on Aug 07, 2024Balaji Amines Limited announced that they will report Q1, 2025 results on Aug 07, 2024Reported Earnings • Jun 23Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.4b (down 30% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 13% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.分析記事 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...お知らせ • Jun 19Balaji Amines Limited, Annual General Meeting, Jul 11, 2024Balaji Amines Limited, Annual General Meeting, Jul 11, 2024, at 12:00 Indian Standard Time.Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.分析記事 • Jun 12Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • May 09Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.7b (down 29% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.お知らせ • May 03Balaji Amines Limited to Report Q4, 2024 Results on May 08, 2024Balaji Amines Limited announced that they will report Q4, 2024 results on May 08, 2024分析記事 • Apr 05There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...分析記事 • Feb 15Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) ForecastsToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the covering analyst...Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹15.24 (vs ₹19.31 in 3Q 2023)Third quarter 2024 results: EPS: ₹15.24 (down from ₹19.31 in 3Q 2023). Revenue: ₹3.92b (down 33% from 3Q 2023). Net income: ₹493.7m (down 21% from 3Q 2023). Profit margin: 13% (up from 11% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.お知らせ • Jan 24Balaji Amines Limited to Report Q3, 2024 Results on Jan 31, 2024Balaji Amines Limited announced that they will report Q3, 2024 results on Jan 31, 2024Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,670, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,718 per share.Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,347, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 159% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,738 per share.分析記事 • Nov 24Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To BeToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the analysts delivering a...Price Target Changed • Nov 22Price target decreased by 16% to ₹2,768Down from ₹3,278, the current price target is an average from 2 analysts. New target price is 36% above last closing price of ₹2,030. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹125 for next year compared to ₹100 last year.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹10.71 (vs ₹28.57 in 2Q 2023)Second quarter 2024 results: EPS: ₹10.71 (down from ₹28.57 in 2Q 2023). Revenue: ₹3.87b (down 39% from 2Q 2023). Net income: ₹347.1m (down 63% from 2Q 2023). Profit margin: 9.0% (down from 15% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 03Balaji Amines Limited to Report Q2, 2024 Results on Nov 08, 2023Balaji Amines Limited announced that they will report Q2, 2024 results on Nov 08, 2023Reported Earnings • Sep 01First quarter 2024 earnings released: EPS: ₹16.28 (vs ₹37.95 in 1Q 2023)First quarter 2024 results: EPS: ₹16.28 (down from ₹37.95 in 1Q 2023). Revenue: ₹4.69b (down 31% from 1Q 2023). Net income: ₹527.3m (down 57% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 22Balaji Amines Limited to Report Q1, 2024 Results on Aug 31, 2023Balaji Amines Limited announced that they will report Q1, 2024 results on Aug 31, 2023分析記事 • Jul 14Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?Key Insights Using the 2 Stage Free Cash Flow to Equity, Balaji Amines fair value estimate is ₹3,541 Current share...お知らせ • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.Upcoming Dividend • Jun 26Upcoming dividend of ₹10.00 per share at 0.4% yieldEligible shareholders must have bought the stock before 03 July 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).Reported Earnings • Jun 24Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.6b (up 1.4% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Jun 22Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...お知らせ • Jun 17Balaji Amines Limited, Annual General Meeting, Jul 10, 2023Balaji Amines Limited, Annual General Meeting, Jul 10, 2023, at 16:00 Indian Standard Time.分析記事 • Jun 09Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last YearBalaji Amines Limited ( NSE:BALAMINES ) has announced that it will be increasing its dividend from last year's...Reported Earnings • May 25Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.7b (up 2.0% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 74% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 22+ 1 more updateBalaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial OfficerBalaji Amines Limited announced resignation of Hemanth Reddy Gaddam as Chief Financial Officer. The full-time director and CFO has resigned to focus on subsidiary company, Balaji Speciality Chemicals Ltd.お知らせ • May 21+ 1 more updateBalaji Amines Limited Appoints Ande Srinivas Reddy as CFOBalaji Amines Limited at the SBM, the board approved appointment of Mr. Ande Srinivas Reddy (DIN: 03169721) as a Whole-time Director & CFO of the Company for remaining tenure of his appointment till 31st March, 2026.お知らせ • May 14Balaji Amines Limited to Report Q4, 2023 Results on May 20, 2023Balaji Amines Limited announced that they will report Q4, 2023 results on May 20, 2023Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,486, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 685% over the past three years.Price Target Changed • Apr 05Price target decreased by 14% to ₹3,790Down from ₹4,428, the current price target is provided by 1 analyst. New target price is 78% above last closing price of ₹2,128. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹142 for next year compared to ₹114 last year.分析記事 • Apr 05Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?While Balaji Amines Limited ( NSE:BALAMINES ) might not be the most widely known stock at the moment, it saw...Recent Insider Transactions • Mar 22MD & Whole Time Director recently bought ₹202k worth of stockOn the 16th of March, Dundurapu Reddy bought around 100 shares on-market at roughly ₹2,019 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. Dundurapu has been a buyer over the last 12 months, purchasing a net total of ₹419k worth in shares.分析記事 • Mar 15Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Recent Insider Transactions • Feb 22Joint MD & Whole-time Director recently bought ₹244k worth of stockOn the 16th of February, Nomula Reddy bought around 98.0 shares on-market at roughly ₹2,494 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. This was Nomula's only on-market trade for the last 12 months.分析記事 • Feb 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under ThreatOne thing we could say about the analysts on Balaji Amines Limited ( NSE:BALAMINES ) - they aren't optimistic, having...Recent Insider Transactions • Feb 14Executive Chairman recently bought ₹1.0m worth of stockOn the 10th of February, Ande Reddy bought around 480 shares on-market at roughly ₹2,166 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ande's only on-market trade for the last 12 months.分析記事 • Feb 08With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting CaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Feb 07Third quarter 2023 earnings released: EPS: ₹19.31 (vs ₹27.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹19.31 (down from ₹27.64 in 3Q 2022). Revenue: ₹5.88b (up 4.2% from 3Q 2022). Net income: ₹625.7m (down 30% from 3Q 2022). Profit margin: 11% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has increased by 72% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 31Balaji Amines Limited to Report Q3, 2023 Results on Feb 06, 2023Balaji Amines Limited announced that they will report Q3, 2023 results on Feb 06, 2023収支内訳Balaji Amines の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:BALAMINES 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Mar 2614,2501,672841031 Dec 2513,8291,441813030 Sep 2513,6431,458816030 Jun 2513,7071,522815031 Mar 2513,9711,575802031 Dec 2414,5831,855828030 Sep 2415,2892,017848030 Jun 2415,6261,954848031 Mar 2416,4152,049833031 Dec 2316,9901,842761030 Sep 2319,0191,974751030 Jun 2321,4892,553771031 Mar 2323,5543,255855031 Dec 2226,6523,8681,050030 Sep 2226,4514,1381,093030 Jun 2225,4334,0101,077031 Mar 2223,2293,684969031 Dec 2119,5983,442896030 Sep 2117,8443,296850030 Jun 2115,4112,956809031 Mar 2113,1332,382735031 Dec 2011,5921,845477030 Sep 209,9461,329429030 Jun 209,3951,186392031 Mar 209,3951,048557031 Dec 199,0951,000328030 Sep 199,2141,029304030 Jun 199,3191,036312031 Mar 199,4681,175332031 Mar 188,6441,132296031 Mar 176,730824266031 Mar 166,4465762330質の高い収益: BALAMINES 非現金収入 のレベルが高いです。利益率の向上: BALAMINESの現在の純利益率 (11.7%)は、昨年(11.3%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BALAMINESの収益は過去 5 年間で年間18.5%減少しました。成長の加速: BALAMINESの過去 1 年間の収益成長率 ( 6.1% ) は、5 年間の平均 ( 年間-18.5%を上回っています。収益対業界: BALAMINESの過去 1 年間の収益成長率 ( 6.1% ) Chemicals業界12.7%を上回りませんでした。株主資本利益率高いROE: BALAMINESの 自己資本利益率 ( 7.9% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/13 21:59終値2026/06/12 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Balaji Amines Limited 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Nilesh GhugeHDFC Securities LimitedJay GandhiHDFC Securities LimitedKeshav LahotiHDFC Securities Limited1 その他のアナリストを表示
分析記事 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...
Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026
分析記事 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...
お知らせ • Jun 09Balaji Amines Limited, Annual General Meeting, Jul 10, 2026Balaji Amines Limited, Annual General Meeting, Jul 10, 2026, at 12:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,043, the stock trades at a trailing P/E ratio of 39.6x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 3.8% over the past three years.
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. Independent Director Suhasini Shah was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
New Risk • May 26New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 18% per year over the past 5 years. High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.5% average weekly change).
分析記事 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹1,833, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.
Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change).
Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,492, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 36% over the past three years.
お知らせ • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.
New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change).
お知らせ • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,265, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.
分析記事 • Jan 09Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...
Price Target Changed • Nov 15Price target decreased by 7.5% to ₹1,709Down from ₹1,847, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₹1,229. Stock is down 40% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.
分析記事 • Nov 14Balaji Amines Limited (NSE:BALAMINES) Screens Well But There Might Be A CatchWith a median price-to-earnings (or "P/E") ratio of close to 27x in India, you could be forgiven for feeling...
Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹10.67 (vs ₹12.65 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.67 (down from ₹12.65 in 2Q 2025). Revenue: ₹3.48b (flat on 2Q 2025). Net income: ₹345.6m (down 16% from 2Q 2025). Profit margin: 9.9% (down from 12% in 2Q 2025). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 03Balaji Amines Limited to Report Q2, 2026 Results on Nov 10, 2025Balaji Amines Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 10, 2025
Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).
お知らせ • Jul 24Balaji Amines Limited to Report Q1, 2026 Results on Aug 02, 2025Balaji Amines Limited announced that they will report Q1, 2026 results at 3:30 PM, Indian Standard Time on Aug 02, 2025
Reported Earnings • Jul 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.0b (down 15% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
お知らせ • Jul 10Balaji Amines Limited, Annual General Meeting, Aug 08, 2025Balaji Amines Limited, Annual General Meeting, Aug 08, 2025, at 12:00 Indian Standard Time.
Price Target Changed • Jul 01Price target increased by 20% to ₹1,972Up from ₹1,640, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of ₹1,825. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.
分析記事 • Jul 01Earnings Tell The Story For Balaji Amines Limited (NSE:BALAMINES) As Its Stock Soars 27%Balaji Amines Limited ( NSE:BALAMINES ) shares have continued their recent momentum with a 27% gain in the last month...
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,673, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 31x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.
Reported Earnings • May 29Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.3b (down 13% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
お知らせ • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.
お知らせ • May 18Balaji Amines Limited to Report Q4, 2025 Results on May 26, 2025Balaji Amines Limited announced that they will report Q4, 2025 results on May 26, 2025
分析記事 • May 17Balaji Amines (NSE:BALAMINES) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
Buy Or Sell Opportunity • May 16Now 21% overvaluedOver the last 90 days, the stock has fallen 2.1% to ₹1,404. The fair value is estimated to be ₹1,163, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,312, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.
分析記事 • Mar 25A Look At The Fair Value Of Balaji Amines Limited (NSE:BALAMINES)Key Insights The projected fair value for Balaji Amines is ₹1,139 based on 2 Stage Free Cash Flow to Equity Current...
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,358, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.
分析記事 • Mar 04Take Care Before Jumping Onto Balaji Amines Limited (NSE:BALAMINES) Even Though It's 25% CheaperUnfortunately for some shareholders, the Balaji Amines Limited ( NSE:BALAMINES ) share price has dived 25% in the last...
Buy Or Sell Opportunity • Feb 19Now 23% overvaluedOver the last 90 days, the stock has fallen 30% to ₹1,395. The fair value is estimated to be ₹1,130, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.
分析記事 • Feb 18This Analyst Just Downgraded Their Balaji Amines Limited (NSE:BALAMINES) EPS ForecastsMarket forces rained on the parade of Balaji Amines Limited ( NSE:BALAMINES ) shareholders today, when the covering...
分析記事 • Feb 16Earnings Report: Balaji Amines Limited Missed Revenue Estimates By 15%It's been a sad week for Balaji Amines Limited ( NSE:BALAMINES ), who've watched their investment drop 17% to ₹1,433 in...
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹10.24 (vs ₹15.24 in 3Q 2024)Third quarter 2025 results: EPS: ₹10.24 (down from ₹15.24 in 3Q 2024). Revenue: ₹3.21b (down 16% from 3Q 2024). Net income: ₹331.9m (down 33% from 3Q 2024). Profit margin: 10% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 05Balaji Amines Limited to Report Q3, 2025 Results on Feb 12, 2025Balaji Amines Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Buy Or Sell Opportunity • Jan 30Now 21% overvaluedOver the last 90 days, the stock has fallen 22% to ₹1,683. The fair value is estimated to be ₹1,385, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Earnings per share has declined by 25%. Revenue is forecast to grow by 42% in 2 years. Earnings are forecast to grow by 96% in the next 2 years.
分析記事 • Jan 17What Does Balaji Amines Limited's (NSE:BALAMINES) Share Price Indicate?Balaji Amines Limited ( NSE:BALAMINES ), might not be a large cap stock, but it saw significant share price movement...
分析記事 • Dec 31Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Price Target Changed • Nov 20Price target decreased by 12% to ₹2,328Down from ₹2,648, the current price target is provided by 1 analyst. New target price is 17% above last closing price of ₹1,996. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₹54.20 for next year compared to ₹63.22 last year.
Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹12.65 (vs ₹10.71 in 2Q 2024)Second quarter 2025 results: EPS: ₹12.65 (up from ₹10.71 in 2Q 2024). Revenue: ₹3.56b (down 6.4% from 2Q 2024). Net income: ₹409.8m (up 18% from 2Q 2024). Profit margin: 12% (up from 9.1% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 14Balaji Amines Limited Announces Company Secretary ChangesBalaji Amines Limited announced that at the board meeting held on November 14, 2024, approved the resignation of Mr. Lakhan S. Dargad as Company Secretary of the Company with effect from closing of business hours on December 30, 2024. Appointment of Mr. Abhijeet S. Kothadiya as a Company Secretary of the Company with effect from December 31, 2024. Mr. Abhijeet S. Kothadiya is an Associate Member of the Institute of Company Secretaries of India having Membership No. 68288 having good amount of experience in corporate and allied laws.
お知らせ • Nov 06Balaji Amines Limited to Report Q2, 2025 Results on Nov 14, 2024Balaji Amines Limited announced that they will report Q2, 2025 results on Nov 14, 2024
分析記事 • Oct 23Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
分析記事 • Aug 13The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%The analyst covering Balaji Amines Limited ( NSE:BALAMINES ) delivered a dose of negativity to shareholders today, by...
分析記事 • Aug 11Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than ExpectedShareholders might have noticed that Balaji Amines Limited ( NSE:BALAMINES ) filed its quarterly result this time last...
Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹13.36 (vs ₹16.28 in 1Q 2024)First quarter 2025 results: EPS: ₹13.36 (down from ₹16.28 in 1Q 2024). Revenue: ₹3.93b (down 15% from 1Q 2024). Net income: ₹432.9m (down 18% from 1Q 2024). Profit margin: 11% (in line with 1Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
分析記事 • Jul 30At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?Balaji Amines Limited ( NSE:BALAMINES ), is not the largest company out there, but it saw a double-digit share price...
お知らせ • Jul 26Balaji Amines Limited to Report Q1, 2025 Results on Aug 07, 2024Balaji Amines Limited announced that they will report Q1, 2025 results on Aug 07, 2024
Reported Earnings • Jun 23Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.4b (down 30% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 13% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
分析記事 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...
お知らせ • Jun 19Balaji Amines Limited, Annual General Meeting, Jul 11, 2024Balaji Amines Limited, Annual General Meeting, Jul 11, 2024, at 12:00 Indian Standard Time.
Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
分析記事 • Jun 12Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • May 09Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.7b (down 29% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.
お知らせ • May 03Balaji Amines Limited to Report Q4, 2024 Results on May 08, 2024Balaji Amines Limited announced that they will report Q4, 2024 results on May 08, 2024
分析記事 • Apr 05There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
分析記事 • Feb 15Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) ForecastsToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the covering analyst...
Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹15.24 (vs ₹19.31 in 3Q 2023)Third quarter 2024 results: EPS: ₹15.24 (down from ₹19.31 in 3Q 2023). Revenue: ₹3.92b (down 33% from 3Q 2023). Net income: ₹493.7m (down 21% from 3Q 2023). Profit margin: 13% (up from 11% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.
お知らせ • Jan 24Balaji Amines Limited to Report Q3, 2024 Results on Jan 31, 2024Balaji Amines Limited announced that they will report Q3, 2024 results on Jan 31, 2024
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,670, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,718 per share.
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,347, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 159% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,738 per share.
分析記事 • Nov 24Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To BeToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the analysts delivering a...
Price Target Changed • Nov 22Price target decreased by 16% to ₹2,768Down from ₹3,278, the current price target is an average from 2 analysts. New target price is 36% above last closing price of ₹2,030. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹125 for next year compared to ₹100 last year.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹10.71 (vs ₹28.57 in 2Q 2023)Second quarter 2024 results: EPS: ₹10.71 (down from ₹28.57 in 2Q 2023). Revenue: ₹3.87b (down 39% from 2Q 2023). Net income: ₹347.1m (down 63% from 2Q 2023). Profit margin: 9.0% (down from 15% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 03Balaji Amines Limited to Report Q2, 2024 Results on Nov 08, 2023Balaji Amines Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Reported Earnings • Sep 01First quarter 2024 earnings released: EPS: ₹16.28 (vs ₹37.95 in 1Q 2023)First quarter 2024 results: EPS: ₹16.28 (down from ₹37.95 in 1Q 2023). Revenue: ₹4.69b (down 31% from 1Q 2023). Net income: ₹527.3m (down 57% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 22Balaji Amines Limited to Report Q1, 2024 Results on Aug 31, 2023Balaji Amines Limited announced that they will report Q1, 2024 results on Aug 31, 2023
分析記事 • Jul 14Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?Key Insights Using the 2 Stage Free Cash Flow to Equity, Balaji Amines fair value estimate is ₹3,541 Current share...
お知らせ • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.
Upcoming Dividend • Jun 26Upcoming dividend of ₹10.00 per share at 0.4% yieldEligible shareholders must have bought the stock before 03 July 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).
Reported Earnings • Jun 24Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.6b (up 1.4% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Jun 22Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
お知らせ • Jun 17Balaji Amines Limited, Annual General Meeting, Jul 10, 2023Balaji Amines Limited, Annual General Meeting, Jul 10, 2023, at 16:00 Indian Standard Time.
分析記事 • Jun 09Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last YearBalaji Amines Limited ( NSE:BALAMINES ) has announced that it will be increasing its dividend from last year's...
Reported Earnings • May 25Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.7b (up 2.0% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 74% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 22+ 1 more updateBalaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial OfficerBalaji Amines Limited announced resignation of Hemanth Reddy Gaddam as Chief Financial Officer. The full-time director and CFO has resigned to focus on subsidiary company, Balaji Speciality Chemicals Ltd.
お知らせ • May 21+ 1 more updateBalaji Amines Limited Appoints Ande Srinivas Reddy as CFOBalaji Amines Limited at the SBM, the board approved appointment of Mr. Ande Srinivas Reddy (DIN: 03169721) as a Whole-time Director & CFO of the Company for remaining tenure of his appointment till 31st March, 2026.
お知らせ • May 14Balaji Amines Limited to Report Q4, 2023 Results on May 20, 2023Balaji Amines Limited announced that they will report Q4, 2023 results on May 20, 2023
Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,486, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 685% over the past three years.
Price Target Changed • Apr 05Price target decreased by 14% to ₹3,790Down from ₹4,428, the current price target is provided by 1 analyst. New target price is 78% above last closing price of ₹2,128. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹142 for next year compared to ₹114 last year.
分析記事 • Apr 05Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?While Balaji Amines Limited ( NSE:BALAMINES ) might not be the most widely known stock at the moment, it saw...
Recent Insider Transactions • Mar 22MD & Whole Time Director recently bought ₹202k worth of stockOn the 16th of March, Dundurapu Reddy bought around 100 shares on-market at roughly ₹2,019 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. Dundurapu has been a buyer over the last 12 months, purchasing a net total of ₹419k worth in shares.
分析記事 • Mar 15Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Recent Insider Transactions • Feb 22Joint MD & Whole-time Director recently bought ₹244k worth of stockOn the 16th of February, Nomula Reddy bought around 98.0 shares on-market at roughly ₹2,494 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. This was Nomula's only on-market trade for the last 12 months.
分析記事 • Feb 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under ThreatOne thing we could say about the analysts on Balaji Amines Limited ( NSE:BALAMINES ) - they aren't optimistic, having...
Recent Insider Transactions • Feb 14Executive Chairman recently bought ₹1.0m worth of stockOn the 10th of February, Ande Reddy bought around 480 shares on-market at roughly ₹2,166 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ande's only on-market trade for the last 12 months.
分析記事 • Feb 08With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting CaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Feb 07Third quarter 2023 earnings released: EPS: ₹19.31 (vs ₹27.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹19.31 (down from ₹27.64 in 3Q 2022). Revenue: ₹5.88b (up 4.2% from 3Q 2022). Net income: ₹625.7m (down 30% from 3Q 2022). Profit margin: 11% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has increased by 72% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 31Balaji Amines Limited to Report Q3, 2023 Results on Feb 06, 2023Balaji Amines Limited announced that they will report Q3, 2023 results on Feb 06, 2023